|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
1998-9-29
|
|
pubmed:abstractText |
Pulmonary fibrosis, a frequent manifestation of systemic sclerosis (SSc), is considered incurable. Our aim was to assess the effect of therapy with intravenous (i.v.) cyclophosphamide on the course of pulmonary fibrosis in patients with SSc.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0315-162X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1325-9
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:9676764-Adult,
pubmed-meshheading:9676764-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:9676764-Cyclophosphamide,
pubmed-meshheading:9676764-Female,
pubmed-meshheading:9676764-Humans,
pubmed-meshheading:9676764-Injections, Intravenous,
pubmed-meshheading:9676764-Male,
pubmed-meshheading:9676764-Middle Aged,
pubmed-meshheading:9676764-Neutrophils,
pubmed-meshheading:9676764-Pilot Projects,
pubmed-meshheading:9676764-Prospective Studies,
pubmed-meshheading:9676764-Pulmonary Fibrosis,
pubmed-meshheading:9676764-Respiratory Function Tests,
pubmed-meshheading:9676764-Scleroderma, Systemic,
pubmed-meshheading:9676764-Treatment Outcome
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
|
|
pubmed:affiliation |
Department of Radiology, Jefferson Medical College, Philadelphia, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.
|
